People · Operator
Named in public records as an officer, director or promoter · active 2009–2024 · Other Health Care, Healthtech, Pharma, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| ExploraMed NC7, Inc. | — | Other Health Care | Series C | $181.5M | $752.1M | 2015 |
| Endogastric Solutions Inc | — | Other Health Care | Series C | $177.3M | $557.6M | 2009 |
| Cala Health, Inc. | — | Healthtech | Series C | $166.1M | $370.1M | 2021 |
| Tallac Therapeutics, Inc. | — | Pharma | Series C | $61.6M | $2.2B | 2020 |
| MediSix Therapeutics, Inc. | — | Biotechnology | Series B | $42.9M | $647.6M | 2021 |
| Altura Medical, Inc. | — | Other Health Care | Series A | $27.0M | $121.1M | 2011 |
| Second Genome, Inc. | — | Biotechnology | Series A | $5.0M | $180.8M | 2011 |
Michael Carusi at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael Carusi on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Corey Goodman | 2 | 13 |
| Michael A. Carusi | 2 | 6 |
| Robert Anderson | 1 | 24 |
| Ryan Drant | 1 | 24 |
| Bruce Feuchter | 1 | 12 |
| Joshua Makower | 1 | 10 |
| Isaac Cheng | 1 | 9 |
| George Wallace | 1 | 8 |
| Jeani Delagardelle | 1 | 8 |
| Michael Burke | 1 | 7 |
| Scott Ward | 1 | 7 |
| ROBERT CROCE | 1 | 7 |
| Robert W. Croce | 1 | 7 |
| Brent Ahrens | 1 | 7 |
| David Milne | 1 | 7 |
| Renee Ryan | 1 | 6 |
| John Kuelper | 1 | 6 |
| William Greene | 1 | 6 |
| Robert K. Anderson | 1 | 6 |
| Uri Geiger | 1 | 6 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.